Fragment, Modified GRF, Ipamorelin 12mg (Blend)

Fat Metabolism + Amplified GH Release. The Complete Metabolic Research Stack.

where to buy peptides You’ve researched growth hormone secretagogues. You know Modified GRF (another name for CJC-1295 No DAC) and Ipamorelin work together for clean, amplified GH pulses. But what if your research protocol also requires studying direct lipolysis — fat metabolism — without the confounding effects of systemic GH elevation?

Enter the Fragment, Modified GRF, Ipamorelin 12mg (Blend) .

This three-peptide blend combines:

• Fragment (AOD-9604 / HGH Fragment 176-191) for direct lipolysis research

• Modified GRF (CJC-1295 No DAC) for GH pulse amplification

• Ipamorelin for clean, prolonged GH release

Three peptides. Three complementary mechanisms. One vial.

 

That’s sophisticated metabolic peptide science .

---

What’s Actually in the Vial?

Straight facts. No mystery fillers.

Lyophilized powder. Sterile. ≥99% purity for all three peptides. Third-party tested. Vacuum-sealed amber glass vial.

Three peptides. One vial. Balanced triple ratio.

That’s advanced peptide science for metabolic research.

---

Why This Triple Blend? (The Enthusiast Take)

You know Modified GRF and Ipamorelin. But Fragment is different. Here’s why putting them together creates something unique.

Modified GRF (CJC-1295 No DAC) is your amplifier. It binds to GHRH receptors on the pituitary and turns up the volume on any GH release signal. No DAC means a sharp, pulsatile amplification — not a flat, constant elevation.

Ipamorelin is your clean starter. It initiates GH release with no prolactin, no cortisol, no appetite spike. It’s the cleanest GHRP available.

Fragment (AOD-9604 / HGH 176-191) is completely different. It’s not a secretagogue — it doesn’t cause GH release at all. Instead, it’s a modified fragment of the GH molecule that retains the fat-metabolism properties of GH without affecting:

• Blood glucose (no insulin resistance risk)

• IGF-1 levels (no proliferation signals)

• Growth hormone receptors (different mechanism)

Together: Modified GRF + Ipamorelin give you clean, amplified GH release for studying recovery, repair, and anabolic pathways. Fragment lets you study lipolysis — fat metabolism — in parallel, without the confounding effects of systemic GH elevation.

That’s not just a blend. That’s a complete metabolic research tool in one vial.

---

Fragment vs. Modified GRF vs. Ipamorelin: Distinct Mechanisms

Each peptide works through a different pathway. No competition. No overlap. Just parallel, complementary mechanisms.

That’s the kind of peptide science that enables sophisticated metabolic research.

---

The Technical Expert Breakdown (Still Friendly)

For those who want mechanisms without the lecture:

Modified GRF (CJC-1295 No DAC) – GHRH analog

• Also known as CJC-1295 without Drug Affinity Complex

• Binds to GHRH receptors on pituitary somatotrophs

• Amplifies amplitude of endogenous GH pulses

• ~30-minute half-life → clean pulsatile release

• Does not interfere with natural GH feedback loops

• Synergizes with Ipamorelin for greater GH output

Ipamorelin – Third-generation GHRP

• Binds to ghrelin (GHS-R1a) receptors

• Potent GH release with no significant prolactin/cortisol elevation

• No appetite stimulation

• Prolonged GH duration (60-90 minutes)

• Selective for GH pathway only

Fragment (AOD-9604 / HGH 176-191)

• Modified 16-amino-acid fragment of hGH (amino acids 176-191)

• Binds to distinct receptors in adipose tissue

• Activates lipolysis via beta-adrenergic and cAMP pathways

• No effect on blood glucose (unlike full GH)

• No effect on IGF-1 (unlike full GH)

• No effect on growth promotion (unlike full GH)

• Half-life: ~30-60 minutes

Triple mechanism synergy:

These three mechanisms are complementary and non-interfering. Modified GRF + Ipamorelin work through the pituitary. Fragment works directly on adipose tissue. No overlap. No competition. Just parallel pathways you can study simultaneously.

That’s the kind of peptide science that enables sophisticated metabolic research.

---

Reconstitution & Dosing (Laid-Back Version)

Same simplicity as our other blends. Just three peptides in one vial.

What you need:

• Bacteriostatic water

• Insulin syringe (0.5ml or 1ml, 30–31 gauge)

• Alcohol wipes

Quick math:

Add 2ml of bacteriostatic water to the vial.

Now each 0.1ml (10 units on a 1ml syringe) contains:
→ ~200mcg Fragment
→ ~200mcg Modified GRF (CJC-1295 No DAC)
→ ~200mcg Ipamorelin

Alternative: Lower concentration for finer dosing

Add 3ml of bacteriostatic water instead.

Each 0.1ml (10 units) then contains:
→ ~133mcg of each peptide

Common dosing for research protocols (using 2ml reconstitution):

Best practice for this blend:

Administer on an empty stomach (at least 2 hours after eating, 30 minutes before). This condition optimizes:

• GH release (glucose/insulin suppress GH)

• Lipolysis (fasted state maximizes fatty acid availability)

Timing protocols:

• Morning (upon waking): Aligns with natural circadian GH peak and fasted lipolysis

• Pre-exercise (30-60 minutes before): For exercise metabolism studies

• Bedtime: Less common for Fragment (lipolysis research typically daytime)

Store in refrigerator after reconstitution. Use within 30 days.

Reminder: This information is for educational and research purposes only. Always follow institutional guidelines.

---

Who Is This Triple Blend For?

• Metabolism researchers studying lipolysis and fat oxidation

• Exercise physiologists examining energy substrate utilization

• Obesity and metabolic syndrome researchers

• Researchers who want to study GH and lipolysis in parallel

• Any lab interested in the distinct mechanisms of GH fragments vs. full GH

• Researchers who value clean data (no prolactin, cortisol, or appetite confounders)

This blend is not for:

• First-time peptide researchers (start with single peptides or two-peptide blends)

• Studies requiring systemic GH effects (use full GH or different secretagogues)

• Research protocols that need to isolate GH from lipolysis (use Fragment alone)

---

Triple Blend vs. Other Options: Comparison

The triple blend is the only option that gives you amplified GH release AND direct lipolysis research in one injection — with zero side effects.

---

Why Modified GRF (Not CJC-1295 With DAC)?

Some researchers ask: why Modified GRF (No DAC) instead of CJC-1295 with DAC?

For metabolic research that includes Fragment, pulsatile GH more closely mimics natural physiology. Modified GRF (No DAC) is the correct choice.

---

What About Purity and Testing?

Triple the peptides means triple the testing.

Every batch of the Fragment, Modified GRF, Ipamorelin 12mg (Blend) is tested by an independent, ISO-certified lab. You receive:

• HPLC purity report (≥99% for each of the three peptides)

• Mass spectrometry confirmation for all three

• Endotoxin and bioburden testing

• Amino acid analysis (critical for Fragment’s specificity)

A scannable QR code on each vial links directly to batch-specific data.

That’s real peptide science transparency.

---

Storage & Handling

Allow vial to reach room temperature before adding bacteriostatic water. Swirl gently for 60-90 seconds — three peptides may take slightly longer to fully dissolve.

Fragment and Modified GRF are stable but handle with standard peptide care.

What is Fragment?
Fragment refers to AOD-9604 or HGH Fragment 176-191 — a 16-amino-acid peptide corresponding to the C-terminal region of human growth hormone. It retains the lipolytic (fat-metabolizing) properties of GH without affecting blood glucose or IGF-1.

What is Modified GRF?
>>>>>Modified GRF is another name for CJC-1295 without DAC (Drug Affinity Complex). It’s a GHRH analog that amplifies natural GH pulses without flattening the pulsatile rhythm.

Is Fragment the same as growth hormone?
No. Fragment is a modified fragment of the GH molecule. It does not bind to the classical GH receptor and does not produce systemic GH effects. It works through distinct pathways in adipose tissue.

Does Fragment affect blood sugar?
>>>>>No. Unlike full GH, Fragment does not cause insulin resistance or blood glucose elevation. This is a key differentiator for metabolic research.

Does Fragment cause GH release?
No. Fragment is not a secretagogue. It does not stimulate the pituitary to release GH. Its effects are direct on adipose tissue.

Why combine Fragment with Modified GRF and Ipamorelin?
Parallel pathway research. Modified GRF + Ipamorelin let you study GH-mediated effects (recovery, repair, anabolic pathways). Fragment lets you study direct lipolysis. One injection, two distinct mechanisms — with zero side effects.

Is this blend cleaner than using GHRP-2 or GHRP-6?
Yes. Ipamorelin has no prolactin, no cortisol, and no appetite effects. GHRP-2 and GHRP-6 both have mild to moderate elevations in these areas. For cleanest data, this blend is superior.

How long does one 12mg vial last?
>At 100mcg of each, once daily: ~40 days.
>At 100mcg of each, twice daily: ~20 days.
>At 200mcg of each, once daily: ~20 days.
>At 200mcg of each, twice daily: ~10 days.

Why empty stomach for this blend?
>>>>>Two reasons: (1) glucose and insulin suppress GH release, so Modified GRF + Ipamorelin work best fasted; (2) lipolysis is maximized in a fasted state (low insulin, elevated fatty acid availability). Same condition serves both mechanisms.

---

Research Applications Summary

---

The Bottom Line

You understand that peptide science is about more than just GH release. It’s about studying specific pathways with precise tools — and keeping your data clean.

The Fragment, Modified GRF, Ipamorelin 12mg (Blend) gives you:

• Three complementary peptides in one vial

• Precise 1:1:1 ratio (4mg each)

• ≥99% purity, third-party tested for all three

• Modified GRF (No DAC) for pulsatile GH amplification

• Ipamorelin for clean, prolonged GH release — no prolactin, cortisol, or appetite effects

• Fragment (AOD-9604) for direct lipolysis research — no blood glucose or IGF-1 effects

This is not a beginner’s blend. This is for metabolic researchers who want to study GH-mediated anabolic pathways AND direct lipolysis in parallel — from a single injection, with the cleanest side effect profile available.

Research smart. Target both pathways. Keep your data clean.

---

This product is intended for laboratory research and scientific study purposes only. Not for human consumption or veterinary use outside of approved research protocols. Always comply with local regulations regarding peptide research.